Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03285711
Brief Title: Study to Evaluate the Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)

First Submitted : September 14, 2017
First Submitted that Met QC Criteria : September 14, 2017
First Posted : September 18, 2017

Results First Submitted : May 1, 2020
Results First Submitted that Met QC Criteria : May 1, 2020
Results First Posted : May 18, 2020

Last Update Submitted that Met QC Criteria : May 1, 2020
Last Update Posted : May 18, 2020